Cingulate Inc. Banner Image

Cingulate Inc.

  • Ticker CING
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cingulate Inc. Logo Image
  • 11-50 Employees
  • Based in Kansas City, Kansas
Cingulate Inc. is a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. WithMore an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where its PTR technology may be employed to develop future product candidates, such as anxiety disorders.
Cingulate Inc.

Most Recent Annual Report

Cingulate Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Cingulate Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!